The university is an anchor investor in a Black-owned venture capital firm’s first strategy that closed last month with more than $60 million in commitments.
The firm has entered into a “leaders strategy” partnership to form a platform that aims to acquire companies and assets in the technology-enabled pharmaceutical solutions industry.
The foundation is considering a maiden alternatives allocation within its portfolio and weighing the addition of hedge fund, infrastructure and private debt investments to fund the allocation.
The firm closed its third fund above its $550 million initial target with the support of existing investors and a substantial personal commitment from its team.